End Tidal Control of Sevoflurane

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02676934

Acronym

EtCntrl

Enrollment

Registered

2016-02-09

Start date

2015-01-31

Completion date

2016-01-31

Last updated

2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia of Living Donor Hepatectomy

Brief summary

the study compares the use of end tidal (Et) control of sevoflurane during anesthesia for living donor hepatectomy versus fresh gas (FGF) control. Et control is hypothesized to be as effective as FGF control with less cost and more operator satisfaction.

Interventions

DEVICEEnd tidal control module in Aisys anesthesia workstation

THE USE OF AUTOMATED CONTROL OF END TIDAL SEVOFLURANE CONCENTRATION TO MAINTAIN ANESTHESIA DURING DONOR HEPATECTOMY

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* all donors scheduled for living donor hepatectomy in Mansoura liver transplant program

Exclusion criteria

* refusal

Design outcomes

Primary

Measure	Time frame
cost of sevoflurane during anesthesia	Intra-operative period

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026